Clinical Study to Evaluate the Safety and Efficacy of Green Tea, Ginger Flavor for digestive wellbeing - Randomized Open Label Phase II Comparative Clinical Studyâ??

The Himalaya Drug Company0 个研究点目标入组 40 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Both male and females in the age group of 18 - 60 years
•2. Subjects who have mild occasional symptoms like abdominal discomfort, heartburn, flatulence, abdominal distension, belching, nausea, vomiting, sense of fullness/heaviness of stomach etc
•3. Subjects willing to give written informed consent
•4. Subjects who are willing to maintain their regular diet pattern and refrain from any other beverages known to relieve digestive disturbances
•5. Subjects who have not participated in similar kind of study in last 4 weeks

•1. Subjects with chronic gastrointestinal disorders and had undergone any surgery
•2. Subjects with chronic infection
•3. Subjects who are on anti-allergic or anti- inflammatory medications
•4. Subjects with established hypertension, renal, hepatic or cardiac failure
•5. Subjects with endocrine disorders
•6. Subjects currently using prescription medication to treat gastric problems
•7. Subjects who are pregnant & lactating women.
•8. Subjects who are not willing to sign informed consent form

发起方